Delivery Order SPE2DB20D3104-SPE2DB25FV5W8
Award Date
3/14/25
Potential Completion Date
3/17/25
Potential Value
$3.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $13,341.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a completion date of June 10, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $17,727.18 for the supply of NURTEC ODT 75 MG TABLET 8S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 6, 2023. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $14,656.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a medication used for various medical purposes. The contract is a Firm Fixed Price Delivery Order with a completion date of January 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $4,381.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of February 12, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $38,137.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a completion date of February 21, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,115.72 firm fixed-price delivery order contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $10,083.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a completion date of July 8, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $5,103.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, and has an ultimate completion date of November 12, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open...
This federal contract award, valued at $191,397.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a completion date of September 26, 2024. This contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $14,758.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the provision of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with an ultimate completion date of November 19, 2024. The contract award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...